Tehran University of Medical Sciences

Science Communicator Platform

Share By
Correlation of Apparent Diffusion Coefficient Values and Peritumoral Edema With Pathologic Biomarkers in Patients With Breast Cancer Publisher Pubmed



Moradi B1, 2 ; Gity M2 ; Etesam F3 ; Borhani A2 ; Ahmadinejad N2 ; Kazemi MA2, 4
Authors

Source: Clinical Imaging Published:2020


Abstract

Purpose: To investigate the relationship between breast cancer imaging features on magnetic resonance imaging (MRI) and histopathological characteristics. Methods and materials: We prospectively enrolled 46 patients who underwent 1.5-T MRI with 68 breast malignant lesions from 2017 until 2019. Peritumoral edema was determined based on visual assessment on T2 weighted imaging. Lesions were categorized into two groups: A: with edema (48 lesions) and B: without edema (20 lesions). Results: The tumor size was not different among two groups but multifocal-multicentric lesions were more common in the group A (70% vs. 35%). The axillary lymph nodes are most involved in group A. ER and PR positive lesions were more common in group B (90% vs. 56.3%) but in the group A, HER2 positive lesions were found to be more common (31.3% vs. 15%). The mean ADC value in tumors and peritumoral regions were lower (0.97 × 10−3 mm2/s, P = 0.023) and higher (1.85 × 10−3 mm2/s, P < 0.0001) in group A, respectively. Peritumoral ADC value was significantly higher in HER2-positive group. Conclusion: Breast carcinomas with peritumoral edema were found to be more multifocal-multicentric, with higher prevalence of axillary lymph node involvement, more HER 2-positive, with lower prevalence of ER/PR-positive, lower tumoral ADC and higher peritumoral ADC values. © 2020
Other Related Docs
12. Diagnostic Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Differentiating Breast Lesions, Journal of Population Therapeutics and Clinical Pharmacology (2022)
15. A Review of Various Modalities in Breast Imaging: Technical Aspects and Clinical Outcomes, Egyptian Journal of Radiology and Nuclear Medicine (2020)